Work

Correction: Comparison of real-world efficacy and safety of nivolumab plus ipilimumab or pembrolizumab combined with platinum-based chemotherapy as first-line treatment for advanced non-small cell lung cancer in a German population

Year: 2026

Type: erratum

Abstract: Correction: Comparison of real-world efficacy and safety of nivolumab plus ipilimumab or pembrolizumab combined with platinum-based chemotherapy as first-line treatment for advanced non-small cell lung cancer in a German population

Source: Cancer Immunology Immunotherapy

DOI: 10.1007/s00262-026-04360-9

Authors: Moritz Weber, Alexander Freiherr von Hammerstein-Equord, Manuela Weinreich, Stefan Andreas, Achim Rittmeyer

Institutions: Universitätsmedizin Göttingen, University of Göttingen

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $4,590

Funder: Georg-August-Universität Göttingen

OpenAlex ID: W7150966214

Cites:

Cited by:

Related to: